Opicapone
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Opicapone is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 24, 2020. In 2024, Medicare Part D spent $15 million on Opicapone across 17,000 claims for 3,276 beneficiaries.
Opicapone is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $24.67 to $24.76 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$24.67 – $24.76
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing OPICAPONE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ONGENTYS 50 MG CAPSULE | $24.7629 per EA | +0.03% |
ONGENTYS 25 MG CAPSULE | $24.6680 per EA | — |
Frequently Asked Questions
What is Opicapone used to treat?
Opicapone is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Opicapone?
In 2024, Medicare Part D spent $15 million on Opicapone across 17,000 claims for 3,276 beneficiaries.
How many Opicapone products are on the market?
The Opicapone drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Opicapone?
NADAC reference prices for Opicapone range from $24.6680 to $24.7629 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Opicapone?
1 manufacturer lists Opicapone in NADAC. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals LLC (2).
How has the price of Opicapone changed recently?
Over the past 7 days, 1 Opicapone NDC rose and 0 fell, with a market-wide average change of +0.0%.